The FFscope F650 brings industrial-scale scanning to clinical hematology.

FFscope F650 Automatic Blood Cell Morphology Analyzer

Blood cell morphology analysis has long depended on the skilled eye of the laboratory technologist—a process that is slow, subjective, and increasingly unsustainable as caseloads rise. The FFscope F650 tackles this friction head-on, replacing manual microscope inspection with automated full-field digital scanning and deep-learning classification.

The instrument scans over 60,000 microscopic fields per sample, preserving the full spatial distribution of cells on the blood smear. Its proprietary AI model identifies more than 50 cell types with classification accuracy above 95%, and maintains a missed abnormal cell rate below 1%. For the clinical lab, this translates into far fewer false negatives and a dramatically reduced need for manual re-review.

Where most automated analyzers stop at a preliminary flag or a partial scan, the F650 pushes toward a comprehensive morphology report. It generates AI-assisted visual outputs that integrate directly into existing hematology workflows, allowing pathologists to verify results without starting from scratch. The system’s open integration architecture means it can slot into labs already running automated hematology analyzers from multiple vendors.

From a procurement standpoint, the F650 targets the middle tier of China’s hospital system—facilities that cannot afford the capital outlay of a full digital pathology platform but need to process high volumes of routine and abnormal smears. It is a workhorse for the general hematology lab, not a specialized research instrument.

The emergence of products like the F650 signals a broader shift in China’s medical device ecosystem: domestic manufacturers are moving beyond low-cost consumables into high-precision diagnostic hardware. The underlying supply chain—optics, sensors, automated stages, and AI inference chips—is increasingly localized, giving labs in China access to advanced morphology analysis at a price point that reshapes competitive dynamics.

For a laboratory director evaluating throughput and diagnostic confidence, the F650 is simply a tool. But for the system architect, it is a marker: the bottleneck that once defined hematology workflow is being automated away by Chinese manufacturers who can now deliver industrial-grade scanning precision at scale.

Why it matters:
The FFscope F650 compresses a 30-minute manual morphology review into minutes of automated scanning, with a missed abnormal cell rate under 1%. For labs upgrading from manual microscopy, it offers a compliance-ready path to standardized, auditable hematology analysis without the cost of a full digital pathology suite.

View Product →